VR Logo

Alembic Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release


With reference to the captioned subject this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Timolol Maleate Ophthalmic Gel Forming Solution 0.25% and 0.5%.

Please find enclosed herewith our press release.

We request you to kindly take the same on record.

Click here to view PDF